indobufen (Compound)

Synonyms:Indobufen, 63610-08-2, Ibustrin, Indobufen [INN], K-3920, 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid, DTXSID7057789, 6T9949G4LZ, Indobufen (INN), 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoic acid, Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-alpha-ethyl-, (2S)-2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid, Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-.alpha.-ethyl-, K-2930, Indobufene, Indobufenum, K 3920, Indobufene [INN-French], Indobufenum [INN-Latin], 2-(4-(1-Oxo-2-isoindolinyl)phenyl)butyric acid, (+/-)-2-[p-(1-oxo-2-isoindolinyl)phenyl]butyric acid, UNII-6T9949G4LZ, (+/-)-2-(P-(1-OXO-2-ISOINDOLINYL)PHENYL)BUTYRIC ACID, 36690-96-7, EINECS 264-364-4, (+/-)-Indobufen, Enamine_001568, INDOBUFEN [MI], INDOBUFEN [MART.], INDOBUFEN [WHO-DD], Oprea1_118499, SCHEMBL140517, (+-)-2-(4-(1-Oxo-2-isoindolinyl)phenyl)buttersaeure, CHEMBL1765292, DTXCID8031578, 1-Oxo-2-(p-((alpha-ethyl)carboxymethyl)phenyl)isoindoline, CHEBI:135239, (+-)-2-(4-(1,3-Dihydro-1-oxo-2-isoindolyl)buttersaeure, HMS1398H06, AMY33419, BCP04485, Tox21_113871, AC-672, MFCD00572250, s5019, 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-alpha-ethyl-benzeneacetic acid, AKOS015917718, CCG-267421, DB12545, KS-5220, SB66092, NCGC00253758-01, HY-18763, CAS-63610-08-2, CS-0014291, FT-0616451, D07141, D70894, A851741, EN300-18215281, J-521529, Q3798322, Z56804486, (+-)-2-(p-(1-Oxo-2-isoindolinyl)phenyl)butyric acid, 2-(4-(1-CARBOXYPROPYL)PHENYL)-1-ISOINDOLINONE, Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (+-)-, 1-OXO-2-(P-((.ALPHA.-ETHYL)CARBOXYMETHYL)PHENYL)ISOINDOLINE, 2-[4-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)phenyl]butanoic acid, 4-(1,3-Dihydro-1-oxo-(2H)-isoindol-2-yl)-alpha-ethylbenzeneacetic acid, 4-(1,3-DIHYDRO-1-OXO-2H-ISOINDOL-2-YL)-.ALPHA.-ETHYLBENZENEACETIC ACID, Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-alpha-ethyl-, (+-)-, BENZENEACETIC ACID, 4-(1,3-DIHYDRO-1-OXO-2H-ISOINDOL-2-YL)-.ALPHA.-ETHYL-, (+/-)-

Pubchem:PUBCHEM:107641

Id:72bf4718-df2f-5a6c-85f1-e157ef3af55a

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View indobufen's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for indobufen.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with indobufen.

Results found

Linked to

	Label	Description
	BRD-A16296925-001-01-3 Substance (Entity type)	A Substance
	DCSTRUCT ID 01439 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01439; PubChem_CID:107641, FILE=drugcentral_drug_01439.json)
	indobufen (319b0370-95fb-4c21-bf6d-217bfc6c0c39) Collection (Entity type)	Metadatata for indobufen
	indobufen negatively regulates IKZF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telbivudine in similarity relationship with indobufen Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indobufen negatively regulates NTRK2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indobufen negatively regulates S100A8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indobufen negatively regulates APOD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indobufen positively regulates TFPI2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indobufen negatively regulates MYB Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS